Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast Database and a Deep Learning Artificial Neural Network Model-Based Approach

Por um escritor misterioso
Last updated 21 outubro 2024
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Frontiers Adverse Outcome Pathway Development for Assessment of Lung Carcinogenicity by Nanoparticles
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
PDF) Identification of toxicity pathway of diesel particulate matter using AOP of PPARγ inactivation leading to pulmonary fibrosis
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
The 2021 update of the EPA's adverse outcome pathway database
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Frontiers From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Full article: Collaborative efforts are needed among the scientific community to advance the adverse outcome pathway concept in areas of radiation risk assessment
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Integrative Data Mining Approach: Case Study with Adverse Outcome Pathway Network Leading to Pulmonary Fibrosis
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Integrative Data Mining Approach: Case Study with Adverse Outcome Pathway Network Leading to Pulmonary Fibrosis
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
AOP-Wiki
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Toxics, Free Full-Text

© 2014-2024 trend-media.tv. All rights reserved.